Markit Could Win Big In LCH Deal

02 Jun 2011

Markit is said to be poised to gain a major stake and control in the over-the-counter derivatives business, if NYSE Euronext succeeds in its bid for LCH.Clearnet.

Markit is said to be poised to gain a major stake and control in the over-the-counter derivatives business, if NYSE Euronext succeeds in its bid for LCH.Clearnet. NYSE, which partnered with Markit for the bid, would have the option to raise its stake in LCH from its current ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.